ContraVir
Why Robinhood?
You can watch ContraVir and buy or sell other stocks, ETFs, and their options commission-free!About CTRV
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease.
CTRV Key Statistics
Stock Snapshot
ContraVir(CTRV) stock is priced at $3.33, giving the company a market capitalization of 730.3K. It carries a P/E multiple of -0.03.
On 2026-05-04, ContraVir(CTRV) stock opened at —, reached a high of —, and a low of —.
The ContraVir(CTRV)'s current trading volume is 0, compared to an average daily volume of 41.85K.
During the past year, ContraVir(CTRV) stock moved between $0.03 at its lowest and $0.49 at its peak.
During the past year, ContraVir(CTRV) stock moved between $0.03 at its lowest and $0.49 at its peak.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.